Nivolumab vs Pirfenidone

## Nivolumab vs Pirfenidone: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Pirfenidone**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Pirfenidone — N/A.

## Chemical Properties

**Type**: Nivolumab — Antibody; Pirfenidone — Small molecule.